An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma
The purpose of this study is to predict responses to Erbitux as a single agent in patients with Non Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung|Neoplasm Metastasis
DRUG: Cetuximab
Prediction of response to Erbitux with non small cell lung cancer
Radiographic Response
The purpose of this study is to predict responses to Erbitux as a single agent in patients with Non Small Cell Lung Cancer